Where is Acorda headquartered?

Acorda is located in Ardsley, NY.

Who invested in Acorda?

Acorda has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Acorda?

Acorda closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

acorda.com

Acorda

Acorda is a biopharmaceutical firm that develops and commercializes novel therapeutics for the treatment of neurological disorders.

Business Model:

Revenue: $122.7M

Employees: 51-200

Geographic Data

Address: 420 Saw Mill River Rd.

City: Ardsley

State: NY

Zip: 10502

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$10M

Raised Total:

$152M

Social

Facebook

Twitter

Crunchbase

Metrics

4,719,878Website Global Rank

2,007Website Monthly Traffic

Twitter Followers

Description

Acorda is a biopharmaceutical firm that develops and commercializes novel therapeutics for the treatment of neurological disorders.

Contact Phone:
+19143474300

Contact Email:

IPO Details

Acorda went public on 2/10/2006 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/10/2006

Ticker Symbol:
ACOR

IPO Price:
$6/share

Amount Raised:
$33M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2003	Grant	2	$380k	National Institute of Neurological Disorders and Stroke New York State Department of Health National Institute of Neurological Disorders and Stroke New York State Department of Health
12/2002	Grant	1	$980k	NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
10/2006	Post-IPO Equity		$31.5M
8/2001	Grant	1	$100k	NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
1/2001	Series A		$0	Forward Ventures BayStar Capital China Development Industrial Bank (CDIB) Novartis Venture Fund RBC Venture Partners Swiss Life Private Equity Partners Forward Ventures BayStar Capital China Development Industrial Bank (CDIB) Novartis Venture Fund RBC Venture Partners Swiss Life Private Equity Partners
5/2003	Series B	7	$55.3M	Cross Atlantic Partners J.P. Morgan Securities Inc. Forbion Capital Partners MPM Capital Forward Ventures ABN AMRO Fund Easton Capital Easton Capital Cross Atlantic Partners J.P. Morgan Securities Inc. Forbion Capital Partners MPM Capital Forward Ventures ABN AMRO Fund Easton Capital Easton Capital
11/2006	Post-IPO Equity	1	$10M	Paul Capital Paul Capital Paul Capital Paul Capital
10/1997	Grant		$2M
3/2001	Series A	1	$6M	Merrill Lynch Ventures Merrill Lynch Ventures
8/2002	Grant	1	$139k	NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)
2/2006	IPO		$33M
3/2004	Venture Round		$11.5M
1/2001	Series A	6	$33.7M	Forward Ventures Forward Ventures

Acquisitions

Announced Date	Name	Price
1/2016	Biotie Therapies
9/2014	Civitas Therapeutics
2/2012	Neuronex

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details